Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients

被引:386
作者
Malik, RA
Kallinikos, P
Abbott, CA
van Schie, CHM
Morgan, P
Efron, N
Boulton, AJM
机构
[1] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Inst Sci & Technol, Dept Optometry & Neurosci, Manchester M60 1QD, Lancs, England
关键词
diabetic neuropathy; confocal microscope; corneal nerves; surrogate; degeneration; regeneration;
D O I
10.1007/s00125-003-1086-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. The accurate detection, characterization and quantification of human diabetic neuropathy are important to define at risk patients, anticipate deterioration, and assess new therapies. Corneal confocal microscopy is a reiterative, rapid, non-invasive in vivo clinical examination technique capable of imaging corneal nerve fibres. The aim of this study was to define the ability of this technique to quantify the extent of degeneration and regeneration of corneal nerve fibres in diabetic patients with increasing neuropathic severity. Methods. We scanned the cornea and collected images of Bowman's layer (containing a rich nerve plexus) from 18 diabetic patients and 18 age-matched control subjects. Results. Corneal nerve fibre density (F-3=9.6, p<0.0001), length (F-3=23.8, p<0.0001), and branch density (F-3=13.9, p<0.0001) were reduced in diabetic patients compared with control subjects, with a tendency for greater reduction in these measures with increasing severity of neuropathy. Conclusion/Interpretation. Corneal confocal microscopy is a rapid, non-invasive in vivo clinical examination technique which accurately defines the extent of corneal nerve damage and repair and acts as a surrogate measure of somatic neuropathy in diabetic patients. It could represent an advance to define the severity of neuropathy and expedite assessment of therapeutic efficacy in clinical trials of human diabetic neuropathy.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 36 条
[11]   Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy [J].
Greene, DA ;
Arezzo, JC ;
Brown, MB .
NEUROLOGY, 1999, 53 (03) :580-591
[12]   Assessing the sub-basal nerve plexus of the living healthy human cornea by in vivo confocal microscopy [J].
Grupcheva, CN ;
Wong, T ;
Riley, AF ;
McGhee, CNJ .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 30 (03) :187-190
[13]   Intraepidermal nerve fiber density in patients with painful sensory neuropathy [J].
Holland, NR ;
Stocks, A ;
Hauer, P ;
Cornblath, DR ;
Griffin, JW ;
McArthur, JC .
NEUROLOGY, 1997, 48 (03) :708-711
[14]   Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats [J].
Hosotani, H ;
Ohashi, Y ;
Kinoshita, S ;
Matsumoto, T ;
Awata, T .
CURRENT EYE RESEARCH, 1996, 15 (10) :1005-1007
[15]   REVERSAL OF ABNORMAL CORNEAL EPITHELIAL-CELL MORPHOLOGIC CHARACTERISTICS AND REDUCED CORNEAL SENSITIVITY IN DIABETIC-PATIENTS BY ALDOSE REDUCTASE INHIBITOR, CT-112 [J].
HOSOTANI, H ;
OHASHI, Y ;
YAMADA, M ;
TSUBOTA, K .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (03) :288-294
[16]  
HYNDIUK RA, 1977, ARCH OPHTHALMOL-CHIC, V95, P2193
[17]   Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors [J].
Jacot, JL ;
Hosotani, H ;
Glover, JP ;
Lois, N ;
Robison, WG .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1998, 14 (02) :169-180
[18]   Topical treatment with nerve growth factor for corneal neurotrophic ulcers [J].
Lambiase, A ;
Rama, P ;
Bonini, S ;
Caprioglio, G ;
Aloe, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (17) :1174-1180
[19]   MICROANGIOPATHY IN HUMAN DIABETIC NEUROPATHY - RELATIONSHIP BETWEEN CAPILLARY ABNORMALITIES AND THE SEVERITY OF NEUROPATHY [J].
MALIK, RA ;
NEWRICK, PG ;
SHARMA, AK ;
JENNINGS, A ;
AHSEE, AK ;
MAYHEW, TM ;
JAKUBOWSKI, J ;
BOULTON, AJM ;
WARD, JD .
DIABETOLOGIA, 1989, 32 (02) :92-102
[20]  
Malik RA, 2001, ACTA NEUROPATHOL, V101, P367